🔗 Share this article

Texas Attorney General Ken Paxton is taking legal action against the producers of acetaminophen, claiming the firms withheld safety concerns that the medication posed to pediatric neurological development.

The lawsuit follows a month after Former President Trump publicized an unproven link between taking Tylenol - referred to as paracetamol - during pregnancy and autism in young ones.

The attorney general is filing suit against J&J, which previously sold the medication, the only pain reliever recommended for expectant mothers, and the current manufacturer, which presently makes it.

In a official comment, he claimed they "misled consumers by profiting off of discomfort and promoting medication without regard for the potential hazards."

The manufacturer states there is insufficient reliable data linking acetaminophen to autism spectrum disorder.

"These companies lied for decades, deliberately risking numerous people to increase profits," the attorney general, a Republican, declared.

The manufacturer stated officially that it was "deeply concerned by the perpetuation of misinformation on the safety of acetaminophen and the likely effects that could have on the health of women and children in America."

On its website, Kenvue also stated it had "regularly reviewed the pertinent research and there is no credible data that shows a verified association between taking acetaminophen and autism."

Associations representing physicians and medical practitioners share this view.

ACOG has stated acetaminophen - the key substance in acetaminophen - is one of the few options for pregnant women to address discomfort and elevated temperature, which can pose significant medical dangers if ignored.

"In over twenty years of studies on the consumption of paracetamol in pregnancy, not a single reputable study has conclusively proven that the consumption of acetaminophen in any trimester of gestation causes brain development issues in young ones," the group stated.

This legal action references current declarations from the former administration in asserting the medication is reportedly hazardous.

Last month, Trump generated worry from public health officials when he told expectant mothers to "struggle intensely" not to use acetaminophen when sick.

The US Food and Drug Administration then released a statement that medical professionals should think about restricting the use of Tylenol, while also mentioning that "a proven link" between the medication and autism spectrum disorder in minors has not been proven.

Health Secretary Kennedy, who oversees the FDA, had pledged in April to initiate "comprehensive study program" that would establish the cause of autism spectrum disorder in a limited time.

But specialists cautioned that identifying a single cause of autism - considered by experts to be the consequence of a complicated interplay of genetic and environmental factors - would not be simple.

Autism spectrum disorder is a form of lifelong neurodivergence and condition that influences how people experience and interact with the surroundings, and is recognized using medical professional evaluations.

In his court filing, the attorney general - who supports Trump who is running for the Senate - claims the manufacturer and Johnson & Johnson "deliberately disregarded and tried to quiet the science" around acetaminophen and autism spectrum disorder.

This legal action seeks to make the corporations "destroy any promotional materials" that claims acetaminophen is reliable for women during pregnancy.

This legal action parallels the complaints of a assembly of mothers and fathers of children with autism spectrum disorder and attention deficit hyperactivity disorder who filed suit against the producers of acetaminophen in recently.

The court threw out the legal action, declaring investigations from the plaintiffs' authorities was lacking definitive proof.